Cognizant Selected by SITA to Deliver AI-Led Global Finance Transformation on the Cloud

Collaboration will help SITA create a Frontier Finance function - data-driven, innovative and focused on growth and measurable business value - using AI and new ways of working

AMSTERDAM and GENEVA, Oct. 6, 2026 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced that it has been selected by SITA, the world's leading specialist in air transport technology, as the implementation and transformation partner for SITA's SKY program. The groupwide, finance-led initiative will help SITA implement a modern cloud platform across finance, procurement and supply chain processes, designed to deliver measurable business value across SITA's global operations in more than 200 countries and territories.

The transformation is designed to move finance beyond reporting and operational processing, establishing it as a more strategic, growth-focused partner to the business. Cognizant will work with SITA to implement a cloud-based ERP and management platform spanning planning, performance, project management and procurement. By connecting these functions through a shared data foundation, consistent ways of working and AI-led insights, SITA aims to strengthen planning, identify opportunities earlier and align resources more closely with its growth priorities.

Cognizant's AI-first approach combines deep finance transformation expertise with generative AI implementation agents, informed by intellectual property developed through more than 800 cloud ERP projects. It draws on embedded platform AI capabilities and custom agents built using Cognizant's agentic AI capabilities to embed intelligence into planning, forecasting, project management and day-to-day finance activities — helping SITA accelerate delivery and put AI to work across live finance, procurement and project management processes.

"SITA's SKY program is a transformation program aimed at delivering strong business outcomes," said Nicolas Husson, Chief Financial Officer at SITA. "By standardizing core processes on Oracle Fusion Cloud and building AI into how we operate, we aim to create a more agile finance organization and a strong foundation for our next phase of growth."

"SITA plays a critical role in the global air transport ecosystem, and its growth requires an enterprise platform that can scale with the business, with technology and AI serving the strategy rather than defining it," said Saket Gulati, Senior Vice President and Head of Northern Europe at Cognizant. "By bringing together our cloud platform expertise, AI capabilities and end-to-end transformation experience, we will help SITA build a modern data and operating model foundation, embed new ways of working, and help translate technology investment into growth and measurable business value."

"Enterprise platforms are the backbone of how global organizations run, and SITA's SKY program is a great example of what's possible when that backbone is rebuilt for an AI-first world," said Roshan Subudhi, SVP and Head of Global Markets- Intelligent Enterprise Platforms at Cognizant. "By combining Agentic AI capabilities and our Oracle Fusion expertise, we're not just modernizing systems — we're helping SITA reimagine how finance, procurement and supply chain teams work together, so the business can move faster and make smarter decisions at scale."

About Cognizant

Cognizant (NASDAQ: CTSH) is an AI builder and technology services provider, building the bridge between AI investment and enterprise value by building full-stack AI solutions for our clients. Our deep industry, process and engineering expertise enables us to build an organization's unique context into technology systems that amplify human potential, realize tangible returns and keep global enterprises ahead in a fast-changing world. See how at www.cognizant.ai or @cognizant.

For more information, contact:

U.S.

Katrina Cheung

[email protected]

Europe / APAC

Sarah Douglas

[email protected]

India

Vipin Nair

[email protected]

About SITA

SITA is the air transport industry's tech engine, making travel safer, easier, and more sustainable for everyone. From the earliest days of commercial aviation to today's digital frontiers, SITA has been there, connecting the industry and helping it evolve through every leap forward.

With around 2,500 customers, SITA technology supports over 1,000 airports and more than 19,600 aircraft worldwide. It also helps over 70 governments strike the balance between secure borders and seamless journeys. Behind the scenes, SITA bridges 45–50% of the industry's data exchange, enabling a highly complex global network to operate smoothly and reliably, every step of the way.

SITA is transforming fast. From advanced self-service and operations control to airport design and digital borders, it is shaping the next generation of travel through key acquisitions like Materna IPS, ASISTIM, and CCM. It is also expanding beyond aviation with initiatives such as SmartSea, bringing its trusted technologies to cruise, rail, and urban air mobility.

This transformation is about more than new products. SITA is investing in the right skills, tools, and partnerships to help the industry move with greater intelligence and agility, bringing together smart systems, seamless data, and sustainable innovation. Because as global travel surges, flow is everything.

As part of its bold climate strategy, SITA is cutting emissions by 4.2% each year and targeting net zero by 2050. SITA's science-based targets are validated by the SBTi, and its growing portfolio is helping customers reduce their own carbon footprints too.

Owned by the industry and driven by its needs, SITA operates in more than 200 countries and territories.

For more information, contact:

Charles Font

[email protected]

SOURCE Cognizant Technology Solutions

Share this article

Web Model Context Protocol (MCP) enables trusted AI agents to work directly within the Orgvue software platform for faster, defensible workforce decisions

- Orgvue is one of the first software vendors to adopt the WebMCP standard.

- Makes organizational design and modeling accessible to more users and keeps AI agent interactions visible within Orgvue.

- Maintains strict human oversight through auditable, reversible control points, ensuring AI-assisted insights translate into defensible workforce decisions.

LONDON and NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Orgvue, the organizational design and planning software platform, has today announced the availability of its Web Model Context Protocol (WebMCP) interface that enables customers to use trusted AI agents directly within the Orgvue platform.

WebMCP connects a customer's agent of choice to an already-open Orgvue Workspace browser tab. Agents then use pre-built tools within Orgvue to respond to natural language requests, improving usability of the platform and making the organizational design and modeling experience available to more users.

Orgvue is one of the first software vendors to adopt the emerging WebMCP standard, which adds a structured, machine-readable layer on top of the browser interface. This integration allows users to see and understand the actions that AI agents take within its platform. The pre-built tools enable agents to translate high-level restructuring ideas into practical, executable steps, show what the impact on the organization would be, and demonstrate how the change would work in practice.

WebMCP is a visible, governed collaboration between the user, their chosen agent, and Orgvue's organizational model. This collaboration preserves context and gives the user a place to inspect and validate what the agent does before making workforce decisions.

Jessica Modrall, Chief Product Officer at Orgvue, commented:

"As work moves into AI environments, organizations need a robust design framework where innovation meets governance. Orgvue's WebMCP is built to grow alongside our customers, so as new agent capabilities emerge, the underlying workflows, rules, and methodologies carry forward effortlessly. With WebMCP, our customers can achieve consistent, repeatable, and scalable organizational design in a way that's not possible with AI platforms alone."

Crucially, the integration safeguards against increased analytical speed at the expense of data control or security. AI agents can surface analysis and model changes, but no organizational data is updated without explicit human review and validation in Orgvue. This ensures that every confirmed change generates a clear, auditable, and reversible decision record.

While AI accelerates data analysis and pattern recognition, this does not guarantee reliable organizational decision-making at scale. Orgvue provides the governed, secure, and auditable system of design required to translate rapid insights into execution-ready workforce decisions. Whether evaluating team transfers or analyzing span of control across a business unit, outputs remain grounded in a single, trusted organizational baseline.

Orgvue has begun an early access trial with a select number of customers, which is expected to run for six to twelve weeks. WebMCP is now listed in the Anthropic Claude AI connector directory (EU/US/AP) and will become generally available to all customers from January 2027.

About Orgvue

Orgvue is the world's best software platform for workforce transformation. We bring clarity and confidence to workforce design by connecting strategy to structure and the work people do. We unify data from any source to provide actionable insights that enable faster, more informed decisions.

The largest and best-known enterprises and consulting firms use Orgvue to model current and future states of their organization and ensure the right people are doing the right work at the right cost. The company is headquartered in the United Kingdom, with offices in the United States, Canada, the Netherlands, and Australia.

SOURCE Orgvue

Share this article

New AppWork Intelligence capability turns technicians' short and vague completion notes into clear resident communication and structured operational data, with no change to how technicians work

RAMSEY, N.J., Oct. 6, 2026 /PRNewswire/ -- AppWork, the maintenance operations and risk management platform for multifamily property management, today launched Enriched Completion Notes, a new AppWork Intelligence capability that automatically rewrites every Work Order completion note into a complete, professional update for residents and a reliable record for operators.

The capability is live today for all AppWork clients at no additional cost.

The completion note is the last thing a technician writes to complete a job and the first thing a resident reads about it. Written quickly, on a phone, between units, it is typically a word or two: "Fixed," "Replaced lights," "Reset breaker." For residents, that reads as dismissive. For operators, it leaves Work Order history too thin to support reporting, repeat-issue detection, technician coaching, or the documentation that lawsuits, insurance, and warranty claims depend on.

Enriched Completion Notes run in the cloud the moment a technician completes a Work Order. It reads the technician's note alongside the Work Order's description, category, photos, logged parts, and timeline, then produces a single note, written in the technician's voice, that explains what was found, what was done, and the result. It corrects spelling and grammar, removes slang and unprofessional language, and replaces terms that can create liability for a property with plain descriptions of what was observed. The technician's original note is preserved on every Work Order and remains one click away for staff.

"The industry has spent a decade trying to get technicians to write better notes," said Sean Landsberg, Co-founder and CEO of AppWork. "We built AppWork so that every technician actually uses it, which means every Work Order already carries the context a note is missing.

This is the first place we've turned that context directly into something a resident reads. It's also a preview of what AppWork Intelligence will do everywhere else: take the actual data AppWork captures and hand it back to operators as insights they can act on.."

The launch reflects the model that distinguishes AppWork in the maintenance intelligence category. The platform is built so every technician actually uses it, which creates a steady flow of actionable maintenance data that comes directly from the work itself. That data powers AppWork Intelligence, the growing set of AI tools built into the platform. It already includes Work Order Characterization, Triage, Insight Reports, and Auto-Assignment. Enriched Completion notes is the newest addition, with more on the way.

As Appwork Intelligence grows, accuracy stays front and center. Enriched Completion Notes comes with clear guardrails: it is built to elaborate only on what the technician reported, and never adds details they did not provide. Every note stays true to the work that was actually done, so operators can trust what they're reading.

For operators, Enriched Completion Notes delivers improvements across several areas at once: resident communication that names the reported problem and confirms it was addressed; consistent, structured notes that make Work Order history usable for reporting and portfolio analysis; risk management through the removal of liability-creating language and the flagging of sensitive notes, incomplete repairs, pending parts, and repeat issues; and operational visibility for managers through badges on the Work Order that surface what needs a second look.

Enriched Completion Notes is available now to all AppWork clients with no setup or configuration required.

Media Contact

Diana Di Dia

Director of Growth, AppWork

[email protected]

512-552-5798 appworkco.com

SOURCE AppWork

Share this article

SUSS enters Wafer-Cleaning Market with launch of GreenTec Solutions Product Line and first GT200 System

- Product portfolio expansion into growing wafer-cleaning market driven by advanced packaging applications

- GreenTec Solutions enable sustainable wafer cleaning with reduced chemical consumption and without hazardous acids

- Proven TurbulenStrip™1 and CrustBuster™2 technologies extend established SUSS expertise from photomask processing to wafer-level production

- GT200 is the first GreenTec Solutions platform, addressing 200 mm process development, qualification, and production applications

- Scalable roadmap from R&D and qualification to 200 mm and 300 mm high-volume manufacturing

GARCHING, Germany, Oct. 6, 2026 /PRNewswire/ -- SUSS MicroTec SE (MDAX/TecDAX: SMHN), a leading supplier of equipment and process solutions for the semiconductor industry, today announces its entry into the wafer-level cleaning market with the launch of the new GreenTec Solutions product line and the introduction of its first system, the GT200.

The launch expands SUSS' technology portfolio into the growing wafer-cleaning market, which today represents an addressable market of approximately €5.4 billion3 and is driven by advanced packaging, heterogeneous integration and increasing semiconductor demand from AI and high-performance computing applications.

"GreenTec Solutions marks an important milestone in the execution of our Ambition 2030 strategy. By expanding into wafer-level cleaning, we are entering an attractive market with significant long-term growth potential while leveraging proven technologies and process expertise from our existing portfolio. Our differentiated approach combines strong cleaning performance, significantly lower chemical consumption and the elimination of hazardous acids. This creates tangible benefits for customers and positions SUSS for future growth in advanced semiconductor manufacturing," says Burkhardt Frick, Chief Executive Officer of SUSS.

Proven SUSS technology as a competitive differentiator addressing ESG-needs of the semiconductor industry

At the core of the portfolio is a hybrid cleaning approach that combines the proven SUSS process technologies TurbulenStrip™ and CrustBuster™ from the Photomask Solutions segment in a single platform. TurbulenStrip™ incorporates lower-impact batch soaking and single-wafer handling for efficient resist and residue removal, while CrustBuster™ utilizes patented in-situ UV technology to break down and remove organic materials directly at the wafer surface in a single-wafer process chamber. Together, these technologies enable highly efficient residue removal and process stability while helping customers reduce chemical consumption, support their sustainability targets, and lower overall cost-of-ownership.

The GT200 is specifically designed for research and development, process qualification, and production in 200 mm manufacturing environments for MEMS4, RF5, Power Device and CMOS6 applications. In addition to equipment supply, SUSS supports customers through joint evaluation programs, process co-development and recipe optimization services to accelerate adoption, improve process stability and de-risk technology transfers ahead of volume production ramps.

Clear roadmap toward high-volume manufacturing

Following SUSS' strategic approach, all platforms of the GreenTec Solutions product line are designed with a focus on a high degree of modularization and standardization with the GT200 serving as the first member of a scalable GreenTec platform. SUSS will expand its portfolio toward high-volume manufacturing (HVM) with a dedicated 300 mm HVM platform in 2027.

"The GreenTec Solutions product line represents our vision for the next generation of semiconductor manufacturing—where sustainability and process excellence go hand in hand. We are building on decades of experience in demanding photomask applications and transferring this expertise now into eco-friendly wafer-level manufacturing. Together with customers and partners, we develop process solutions that support the next generation of microelectronics with a clear focus on reliability, innovation, and responsible resource use. Due to the strong interest from our customers, we are pulling in the launch of a 300 mm HVM solution," explains Yuta Nagai, Senior Vice President Photomask Solutions at SUSS. A 200 mm HVM platform will follow in 2028. This provides customers with a clear migration path from evaluation to full-scale production.

Please find more information about the GT200 at https://www.suss.com/en/products-solutions/greentec-solutions/wafer-cleaning/gt200

Meet SUSS at SEMICON West

Discover the latest developments in wafer-level cleaning and join our Product Deep Dives at SEMICON West.

Register now: https://www.suss.com/en/company/events/semicon-west

1 TurbulenStrip™ is a trademark of SUSS MicroTec SE

2 CrustBuster™ is a trademark of SUSS MicroTec SE

3 Source: SUSS Research, Yole

4 Micro-Electro-Mechanical Systems

5 Radio Frequency

6 Complementary metal–oxide–semiconductor

Contact

Sabrina Müller

Vice President Investor Relations & Communications

[email protected]

+49 160 94989008

www.suss.com

About the GT200

The GT200 is an eco-friendly manufacturing solution for wafer cleaning and stripping processes. It combines photoresist removal, surface activation, and final cleaning in one configurable platform, helping fabs reduce tool fragmentation, simplify process flows, and improve operational efficiency.

By combining greener process media with advanced technologies adapted from proven solutions developed by SUSS's Photomask Solutions business unit, the GT200 supports shorter process learning cycles, reduced EHS exposure, and lower chemical consumption and hazardous waste generation — without compromising process performance. Its flexible hybrid concept consolidates multiple cleaning and stripping steps, reducing wafer transfers and toolset complexity.

SUSS supports customers throughout implementation with co-development, recipe tuning, and a structured Joint Evaluation Program. This helps accelerate adoption, strengthen process stability, and transfer process know-how from pilot and qualification phases into high-volume manufacturing.

About SUSS

SUSS is a leading global provider of equipment and process solutions for the semiconductor industry. Focused on cutting-edge technology and precision engineering, we enable the production of next-generation microchips and semiconductor devices that power digital progress. Developed in close collaboration with research institutes and industry partners, our solutions fuel the AI and high-performance computing ecosystem and shape the future of intelligent devices and applications worldwide.

Headquartered in Garching, Germany, SUSS has approximately 1,500 employees worldwide and recently generated sales of approximately €500 million. We operate production sites in Germany and Taiwan and development centers in Europe, Asia, and the US, supported by a strong network of sales and service offices with close proximity to our customers. SUSS MicroTec SE is listed on the Frankfurt Stock Exchange (Prime Standard, FWB: SMHN; ISIN DE000A1K0235) and is part of the TecDAX and MDAX indices. For more information, visit www.suss.com.

Legal Disclaimer

Certain statements made in this release are forward-looking statements or may be construed as such. All information and assessments are based on extremely diligent research. However, this publication is made without a warranty. Any liability is excluded. The above statements do not constitute an offer to buy or sell securities. All rights reserved.

SOURCE SUSS MicroTec SE

Share this article

Palace Theatre brings Ray Charles' music back to its stage for one-night-only centennial concert

Country artist Jackson Dean and jazz trumpeter Etienne Charles join all-star lineup for Palace 100 concert

COLUMBUS, Ohio, Oct. 6, 2026 /PRNewswire/ -- The Palace Theatre will celebrate its 100th anniversary by bringing Ray Charles' music back to a stage where he performed throughout his career. CAPA today announced that country artist Jackson Dean and jazz trumpeter Etienne Charles will join host Paul Shaffer and an all-star cast for Palace 100: The Genius of Ray Charles at 7:30 p.m. Saturday, Nov. 14, 2026, at the Palace Theatre in downtown Columbus.

An all-star lineup spans musical genres

Dean and Charles join a lineup that includes Grammy Award-winning R&B and jazz vocalist Patti Austin; multiplatinum singer-songwriter Aloe Blacc; Grammy-nominated gospel singer-songwriter Blessing Offor; Grammy and Academy Award-winning singer Lisa Fischer; Grammy-nominated singer Monica Mancini; and Columbus native, singer and songwriter Billy Valentine. A Guggenheim Fellow, Etienne Charles is known for blending jazz with Afro-Caribbean musical traditions.

Spanning R&B, jazz, gospel, country and contemporary music, the lineup reflects the range of styles Charles explored throughout his career.

Paul Shaffer and Gregg Field bring personal Ray Charles connections

Paul Shaffer, David Letterman's longtime musical director and bandleader, will host the evening. Shaffer performed with Charles on programs including Saturday Night Live and Late Night with David Letterman. The concert will be produced by Grammy and Emmy recipient, music producer, and former drummer for Ray Charles, Gregg Field.

"Ray Charles represents the kind of musical excellence that transcends genres, generations and boundaries," CAPA Vice President of Marketing and Sales Peter Keiser said. "Bringing his music back to the Palace honors his extraordinary legacy and the theatre's history as a place where great artists and unforgettable moments continue to come alive."

Palace 100 at a glance

- Event: Palace 100: The Genius of Ray Charles

- Occasion: The Palace Theatre's 100th anniversary

- Date: Saturday, Nov. 14, 2026

- Time: 7:30 p.m.

- Location: Palace Theatre, 34 W. Broad St., Columbus, Ohio

- Host: Paul Shaffer

- Producer: Gregg Field

- Featured artists: Aloe Blacc, Billy Valentine, Blessing Offor, Jackson Dean, Patti Austin, Lisa Fischer, Etienne Charles and Monica Mancini

- Tickets: Starting at $62.50 at the CAPA Ticket Center at the Ohio Theatre, 39 E. State St.; online at www.capa.com; or by phone at 614-469-0939

- Significance: A one-night-only concert created for the Palace Theatre's centennial

An exclusive concert for the Palace Theatre's 100th anniversary

Created specifically for the Palace Theatre's centennial, the concert will be performed only once, in Columbus, and will not tour to other cities. Charles performed at the Palace Theatre throughout his career, most recently on June 6, 1992. Bringing his music back to the Palace links the theatre's history with a new generation of performers and audiences.

"A theatre doesn't reach its 100th anniversary by simply surviving—it gets there by becoming part of the lives of generations of people," Field said. "The Palace Theatre has that kind of history. For its centennial, we're bringing the music of Ray Charles, who performed on that very stage, back to the Palace with an extraordinary collection of artists. Having worked with Ray for many years, I can't imagine a more powerful way to honor his legacy and celebrate 100 years of this extraordinary theatre."

National talent and Columbus musicians share the Palace stage

The program will include a special rendition of "America the Beautiful," one of Charles' best-known interpretations. The concert will bring nationally recognized artists together with musicians from the Columbus Symphony Orchestra, Columbus Jazz and The Ohio State University School of Music. Led by Grammy-nominated conductor Chris Walden, the orchestra will feature Grammy-nominated guitarist Dean Parks, bassist Nathan East (Eric Clapton), Columbus Hammond organist and former Ray Charles band member Bobby Floyd, saxophonist Tom Scott (Blues Brothers) and Grammy-winning keyboardist Matt Rollings. The concert also marks a homecoming for Columbus native Billy Valentine, a performer and songwriter who co-wrote "My World," the title track of Charles' 1993 album.

The Palace Theatre celebrates 100 years

Billed as "A Theatre of a Thousand Wonders," the Palace Theatre opened Nov. 8, 1926, as a vaudeville house. Over the next century, its stage welcomed generations of artists and audiences across nearly every performing arts genre. Six days after the Palace's 100th birthday, Palace 100: The Genius of Ray Charles will celebrate that history by returning Charles' music to its stage.

The concert is one of several programs CAPA has planned in celebration of the Palace Theatre's centennial. Visit www.capa.com/100-celebration-palace for additional information.

Media Contact:

Shannon McCormick

[email protected]

614-477-2719

SOURCE CAPA

Share this article

VistaJet's awarded Luxury Experience Commendation joining a run of recent brand honours - including an "Exemplary Brand Image" Award at the 15th China Finance Summit, plus recognition for XO in Condé Nast Traveler's 2026 Readers' Choice Awards and Manhattan Magazine's Best of Manhattan 2026

LONDON, Oct. 6, 2026 /PRNewswire/ -- Vista Global Holding Limited ("Vista"), the world's leading global business aviation company, achieves international recognition for its portfolio of brands, VistaJet and XO, reflecting a series of accolades for service excellence and customer experience across private aviation.

VistaJet Receives Luxury Experience Commendation 

VistaJet, the world's first and only global business aviation company, has been presented with a Luxury Experience Commendation by The Luxury Report, in recognition of the company's exceptional service excellence in private aviation.

Alongside its main Luxury Experience Awards programme, The Luxury Report - in partnership with the Lexden Group - selects a small number of businesses each year to receive a Commendation in recognition of consistently exceptional customer experience. Previous recipients include Sanlorenzo MED Monaco Lounge.

The Commendation was presented to VistaJet by Christopher Brooks, Managing Director of the Lexden Group, and JanosNieddu, CEO of CDN Media, publisher of The Luxury Report. It was accepted on behalf of the company by Ian Moore, Chief Commercial Officer of VistaJet.

Christopher Brooks, Managing Director of the Lexden Group: "We were privileged to get to know VistaJet through the making of The Ultimate Experience Collection, a publication exploring the intimate customer experiences of twenty ultra-high-net-worth brands, and what became very evident was just how much VistaJet excels in this space. We are delighted to offer this recognition."

Ian Moore, Chief Commercial Officer at VistaJet: "We're extremely proud of this award, which is a recognition of the importance that we place on client service excellence. Our job is to service our customers in the best way we possibly can, from the start of the experience all the way to the end, and we empower our staff to deliver over and above for every individual. We look at every single area of a journey so that we can consistently create a better experience for our Members."

This ethos is reflected beyond the cabin across VistaJet's suite of Member experiences, including its Private World collection of curated ground experiences, VistaPetprogramme for those travelling with pets, and Adventures in the Sky programme for children - each designed to tailor every journey to the individual needs of the Member.

VistaJet Honoured with "Exemplary Brand Image" Award at the 15th China Finance Summit 

The Luxury Experience Commendation adds to a strong run of global external honours. Recognising Vista's strategic investment in the Greater China region and the brand's exceptional service quality for over 15 years in the region, VistaJet was honoured with an Exemplary Brand Image award at the 15th China Finance Summit. The summit was organised in Shanghai by leading Chinese financial and mass media, reaching over 20 million readers, including influential business leaders and decisionmakers across China.

XO Selected for Condé Nast Traveler's 2026 Readers' Choice Awards 

Recognition also stretches across Vista's portfolio of brands. Earlier this year, XO, part of Vista and the world's largest private jet marketplace, was selected for the CondéNast Traveler 2026 Readers' Choice Awards — long regarded as one of the industry's most influential travel recognitions, the Readers' Choice Awards celebrate the brands shaping how people experience the world through service, access and the ability to anticipate evolving traveler expectations.

XO Named Best in Private Aviation Provider by Modern Luxury Manhattan Magazine 

XO has also been named Best Private Aviation provider in Manhattan Magazine's Best of Manhattan 2026 awards. Manhattan is published by Modern Luxury, reaching more than 16 million affluent readers across 22 U.S. markets through a portfolio of 85-plus city and lifestyle titles. XO has been named Best Private Aviation provider in Modern Luxury Manhattan's Best of Manhattan 2026 awards. Manhattan is New York City's leading luxury lifestyle media brand, delivering an insider's perspective on the city's top tastemakers to its most engaged audience. It is part of Modern Luxury, the nation's largest luxury media company, reaching the most affluent audiences in the most prominent cities across the United States. 

Building Momentum Across the Vista Portfolio

Together, these accolades reflect Vista's continued investment in delivering exceptional, personalized experiences globally across its network of brands — from guaranteed availability and on-demand charter to asset-free flight solutions for clients around the world.

About Vista

Vista Global Holding Limited (Vista) is the world's leading global business aviation company providing worldwide business flight services through its network of subsidiaries and a team of over 4,000 experts. A global group headquartered in Dubai, Vista integrates a unique portfolio of companies to offer asset free services to cover all key aspects of business aviation, including guaranteed and on demand global flight coverage, subscription and membership solutions, and trading and management services.

Innovating the industry for over 20 years through continuous investment in talent, technology, and infrastructure, Vista's mission is to provide the most advanced flying services at the very best value — anytime, anywhere around the world.

Vista's extensive industry expertise enables it to deliver comprehensive end-to-end solutions and technology to meet the needs of business aviation clients around the world. These services are offered through its leading brands, including VistaJet and XO.

More Vista information and news at www.vistaglobal.com

SOURCE Vista

Share this article

Serbia and North Macedonia Deepen Tourism and Business Ties Ahead of EXPO 2027 Belgrade

SKOPJE, North Macedonia, Oct. 6, 2026 /PRNewswire/ -- EXPO 2027 Belgrade is bringing Serbia's tourism and business opportunities to North Macedonia at the "Visit Serbia B2B Networking" event at Public Room in Skopje. The event brings together tourism professionals and business representatives to explore cooperation ahead of the first Specialised Expo in the Western Balkans.

As part of Serbia's international roadshow, the event aims to support new travel programmes and business partnerships ahead of EXPO 2027 Belgrade, opening on 15 May 2027.

North Macedonia has confirmed its participation with a pavilion titled "All Rhythms of the Sun", showcasing the country through music, gastronomy, wine, hospitality, nature, tourism, culture and the arts.

Danilo Jerinić, CEO of EXPO 2027 Belgrade, said: "Serbia and North Macedonia share more than a border. Our countries are connected through geography, history, culture and close human ties. EXPO 2027 offers a platform to bring our tourism industries and business communities closer together, develop new partnerships and turn regional connections into lasting opportunities for cooperation."

Bilateral trade in goods reached EUR 1.5 billion in 2025, while Serbia recorded 82,047 tourist arrivals from North Macedonia between January and July 2026, an increase of 22% compared with the same period in 2025.

- Event: Visit Serbia B2B Networking

- Date: Thursday, 8 October 2026, 10:00 a.m.–2:00 p.m.

- Venue: Public Room, Skopje

About EXPO 2027 Belgrade

EXPO 2027 Belgrade, themed "Play for Humanity: Sport and Music for All," will take place from 15 May to 15 August 2027, with more than 140 countries confirmed to participate.

Press contact: [email protected]

More detailed information about Expo 2027 Belgrade can be found at the following LINK.

Share this article

BETHESDA, Md., Oct. 6, 2026 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that Dr. Marnix Bosch, the Company's Chief Technical Officer, will be making an invited keynote presentation entitled "Harnessing Immunity: A Personalised, Multi-Target Approach to Cancer" at the annual UK National Health Service (NHS) CancerCare Oncology Conference on Tuesday, October 6, at 11:30 a.m. UK time.

The CancerCare Conference brings together NHS leaders and clinicians, cancer alliances and other healthcare professionals from across the UK to discuss developments in cancer care, innovation and emerging treatments.

Dr. Bosch will discuss the new era of cancer vaccines, the need for personalized treatments, the unique capabilities of dendritic cell (DC) based cancer vaccines such as DCVax®, clinical trial results, potential combination treatments and related matters. The slide deck will be posted on the Northwest Biotherapeutics website after the NHS conference.

About Northwest Biotherapeutics

Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products that are designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines. The Company's lead program involves DCVax®-L treatment for glioblastoma (GBM). GBM is the most aggressive and lethal form of primary brain cancer, and is an "orphan disease." The Company has completed a 331-patient Phase III trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval in the UK. The MAA is currently undergoing review. The Company has also developed DCVax®-Direct for inoperable solid tumor cancers. It has completed a 40-patient Phase I trial and plans to pursue Phase II trials this year. The Company previously conducted a Phase I/II trial with DCVax-L for advanced ovarian cancer together with the University of Pennsylvania.

Disclaimer

Statements made in this news release that are not historical facts, including statements concerning plans for DCVax® are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "expect," "believe," "intend," "design," "plan," "continue," "may," "will," "anticipate," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those projected in any forward-looking statement. Readers should not rely upon forward-looking statements. There are a number of important factors that could cause actual results to differ materially from those anticipated, including, without limitation, risks related to delays or uncertainties in regulatory processes and decisions, risks related to the Company's ability to achieve timely performance of third parties, risks related to whether the Company's products will be viewed as demonstrating safety and efficacy, risks related to the Company's ongoing ability to raise additional capital, and other risks included in the Company's Securities and Exchange Commission ("SEC") filings. Additional information on the foregoing risk factors and other factors, including Risk Factors, which could affect the Company's results, is included in its SEC filings. Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual plans, results or timelines to differ materially from those projected in any forward-looking statement. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.

CONTACTS

Northwest Biotherapeutics

Dave Innes

804-513-4758

[email protected]

Share this article

DES MOINES, Iowa, Oct. 6, 2026 /PRNewswire/ -- BioSpace, the leader in biopharma news and careers, has revealed the 2026 cohort for its second 40 Under 40 list.

BioSpace's 40 Under 40 honors exemplary biotech and pharma professionals who have distinguished themselves in their companies and their field. The young leaders demonstrate innovation, business impact and commitment to improving outcomes for patients.

"The professionals recognized this year represent the next generation of leaders shaping the future of biopharma," said Josh Goodwin, CEO of BioSpace. "From advancing AI-driven discovery and breakthrough science to leading business strategy, operations, manufacturing and patient advocacy, these individuals are already making a meaningful impact on our industry. Their achievements reflect the depth of talent, innovation and leadership driving better outcomes for patients around the world."

40 Under 40 winners hail from a range of therapeutic areas and business functions. Their companies include small and midsized biotechs, pharmas, technology platforms, and contract development and manufacturing organizations. The 2026 cohort winners are:

- Ioana Aanei, Director, Business Development and Alliance Management, Scribe Therapeutics

- James Andorko, Director, In Vivo Discovery, Kite Pharma, a Gilead Sciences company

- Victoria Assimon, Senior Director, Head of Biology, Maze Therapeutics

- Kaggen Ausma, Vice President, Application Development, Generate:Biomedicines

- Jake Becraft, Co-Founder and CEO, Strand Therapeutics

- Shruthi Bharadwaj, Executive Director, Head of AI Drug Discovery Analytics, Revolution Medicines

- Calvin Chan, Global Head of Insights, Digital and Analytics, Gilead Sciences

- Bob Chen, Senior Vice President, Discovery Systems, OmniAb

- Eddie Chung, CEO, Coastar Therapeutics

- Pedro Coelho, CEO and Founder, Biorce

- Beryl Cummings, Senior Director, Team Lead and Chief of Staff, Marea Therapeutics

- Mehul Desai, Senior Vice President, Global Medical Affairs and Advocacy, Enable Injections

- Josh Haimson, Co-Founder and CEO, Inductive Bio

- Louisa Helms, Principal, Flagship Pioneering

- Michelle Ho Huey, Vice President, Strategy and Operations, Renasant Bio

- Ben Hohl, Chief Financial Officer and Head of Corporate Development, Enliven Therapeutics

- Lex Johnson, Chief Platform Officer, Dispatch Bio

- Anastasiia Kamenska, Vice President of Corporate Strategy, Azalea Therapeutics

- Amy Kauffman, Senior Principal Scientist, Bristol Myers Squibb

- Arthur Kuan, Chairman, President and CEO, CG Oncology

- William Leonardi, Director, Program Manager Office, Avid Bioservices

- Klevin Lo, Senior Director, Business Development, Altos Labs; Vice President, Milky Way Investments

- Sophia Lugo, CEO, Radar Therapeutics

- Blake Mandell, Advisor, Transcend Therapeutics

- Narbe Mardirossian, Chief Technology Officer, Terray Therapeutics

- Trevor Martin, Co-Founder and CEO, Mammoth Biosciences

- Saber Meamardoost, Associate Director–Research, Data Science and AI, Boehringer Ingelheim

- Kimberly Nettles, Director of Health Advocacy, Genentech, a member of the Roche Group

- Haichen Nie, Associate Director, Biologics Drug Product Development, Teva Pharmaceuticals

- Kanwal Palla, Senior Director, Research and Development, Slingshot Biosciences

- Nindhana Paranthaman, Vice President, Early Clinical Development, Bicara Therapeutics

- Morgan Paull, Chief Operating Officer, GondolaBio

- Matthew Pierce, Director, Operations, Hikma Pharmaceuticals

- Samantha Piteri-Molina, Vice President of Business and Strategy, Forge Biologics

- Caitlin Prendes, Vice President, CMC, Abcentra

- Zvonimir Vrselja, CEO and Co-Founder, Bexorg

- Hannah Walter, Enterprise Strategic Operations, Parabilis Medicines

- Qing Yu Christina Weng, Chief Medical Officer, Pelage Pharmaceuticals

- Johnny Yu, Chief Scientific Officer, Tahoe Therapeutics

- Christine Zhang, Executive Director and Evanesco Program Lead, BridgeBio

About 40 Under 40

Nominations for 40 Under 40 were open from July 6 to Aug. 24. To be eligible, nominees had to be based in the U.S.; be 39 years of age or younger for the calendar year for which they were considered; work in a leadership role in any size biotech or pharma company operating in the U.S.; and be employed at the company for which they were nominated when winners are announced. Anyone could nominate an individual for consideration, and nominees from all disciplines were welcome. Nominees were required to complete an online submission. Winners are selected by BioSpace committee.

About BioSpace

BioSpace is the hub for life sciences news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe through news, webinars, podcasts, email, advertising and jobs. Learn more and subscribe at biospace.com.

SOURCE BioSpace

Share this article

Professor Vladimir Obradović Unanimously Elected President of IPMA World

ZADAR, Croatia, Oct. 6, 2026 /PRNewswire/ -- Professor Vladimir Obradović has been unanimously elected President of the International Project Management Association (IPMA World).

Obradović takes over the position after serving as Vice President of IPMA, where he was involved in the organisation's international activities and development.

As part of the new leadership team, Tim Jaques (United States) and Giovanni Pisano (Italy) were elected Vice Presidents of IPMA, while professor Mladen Vukomanović (Croatia) was elected Chair of the IPMA Council of Delegates.

IPMA is entering a new phase of global development, aimed at increasing its real-world impact and international visibility by building on the expertise of its Member Associations worldwide.

A key part of this work will focus on strengthening project management capabilities in the private sector, while working with governments and public institutions to improve how major infrastructure and development projects are planned, managed and delivered.

"Sustainability and artificial intelligence will be important priorities as IPMA seeks to support the global project management community by shaping the furure of the profession" said Professor Vladimir Obradović.

Obradović is a professor at the Faculty of Organizational Sciences, University of Belgrade, with extensive academic and professional experience in project and programme management and a long-standing involvement in IPMA's international activities.

About IPMA

The International Project Management Association (IPMA) is a global federation of more than 70 national Member Associations, including organisations from the United States, Germany, China, the United Kingdom, France, Italy, Japan, India, Canada and Australia, focused on advancing professional standards, competencies and practices in project, programme and portfolio management worldwide.

Share this article